BPR provided communications and media relations support to the pan-Canadian Oncology Drug Review (pCODR)

BPR provided communications and media relations support to the pan-Canadian Oncology Drug Review (pCODR) which began accepting submissions this month. Created to assess the clinical evidence and cost effectiveness of cancer drugs, pCODR will use this information to make recommendations to the provinces and
territories to help guide drug funding decisions. www.pcodr.ca